Tag: clinical trials
-
Trial Underway Testing Cancer Drug as Covid-19 Therapy
A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections.
-
FDA Okays One-Time HIV Treatment Clinical Trial
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial.
-
Trial Shows VR Training Helps Correct Lazy Eye in Kids
Clinical trial findings show a digital therapy using virtual reality headsets improves vision in children with amblyopia, or lazy eye, more than corrective lenses alone.
-
Digital Biofeedback Device Shown to Reduce PTSD
Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder.
-
FDA Sends Warning on Covid-19 Food Therapy Trials
The Food and Drug Administration released yesterday a warning letter sent in late August to a company conducting clinical trials of a food therapy for Covid-19 symptoms.
-
Trial Shows Synthetic Antibody Slows Cognitive Decline
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease.
-
Trial Shows Wearable Device Monitors Heart Rhythm Indicators
Results from a clinical trial show a device worn on the wrist can measure two key indicators of heart health as accurately as an electrocardiogram.
-
Small Biz Grant to Advance Cancer Chemotherapy Patch
A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors.
-
AI-Analyzed Liquid Biopsy IDs Early Lung Cancer
A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease.
-
CEPI Funding Covid-19 Variant Vaccine
A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI.